152 related articles for article (PubMed ID: 25098376)
1. Relevance of target-organ lesions as predictors of mortality in patients with diabetes mellitus.
Bianco HT; Izar MC; Fonseca HA; Póvoa RM; Saraiva JF; Forti A; Jardim PC; Introcaso L; Yugar-Toledo J; Xavier HT; Faludi AA; Fonseca FA
Arq Bras Cardiol; 2014 Oct; 103(4):272-81. PubMed ID: 25098376
[TBL] [Abstract][Full Text] [Related]
2. QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up.
Stettler C; Bearth A; Allemann S; Zwahlen M; Zanchin L; Deplazes M; Christ ER; Teuscher A; Diem P
Diabetologia; 2007 Jan; 50(1):186-94. PubMed ID: 17096116
[TBL] [Abstract][Full Text] [Related]
3. The association between left ventricular global longitudinal strain, renal impairment and all-cause mortality.
Krishnasamy R; Isbel NM; Hawley CM; Pascoe EM; Leano R; Haluska BA; Stanton T
Nephrol Dial Transplant; 2014 Jun; 29(6):1218-25. PubMed ID: 24516227
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors.
Cea Soriano L; Johansson S; Stefansson B; Rodríguez LA
Cardiovasc Diabetol; 2015 Apr; 14():38. PubMed ID: 25909295
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study.
Cardoso CR; Salles GF; Deccache W
J Diabetes Complications; 2003; 17(4):169-78. PubMed ID: 12810239
[TBL] [Abstract][Full Text] [Related]
6. Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: the Taichung Diabetes Study.
Lin CC; Chen CC; Kung PT; Li CI; Yang SY; Liu CS; Lin WY; Lee CC; Li TC; Kardia SL
Cardiovasc Diabetol; 2012 Oct; 11():131. PubMed ID: 23083001
[TBL] [Abstract][Full Text] [Related]
7. Carotid intima-media thickness is an independent predictor of all-cause mortality and cardiovascular morbidity in patients with diabetes mellitus type 2 and chronic kidney disease.
Roumeliotis A; Roumeliotis S; Panagoutsos S; Theodoridis M; Argyriou C; Tavridou A; Georgiadis GS
Ren Fail; 2019 Nov; 41(1):131-138. PubMed ID: 30909780
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose Study.
Afsharian S; Akbarpour S; Abdi H; Sheikholeslami F; Moeini AS; Khalili D; Momenan AA; Azizi F; Hadaegh F
Diabetes Metab Res Rev; 2016 Sep; 32(6):596-606. PubMed ID: 26787367
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality.
Roussel R; Hadjadj S; Pasquet B; Wilson PW; Smith SC; Goto S; Tubach F; Marre M; Porath A; Krempf M; Bhatt DL; Steg PG
Int J Cardiol; 2013 Aug; 167(4):1380-4. PubMed ID: 22560911
[TBL] [Abstract][Full Text] [Related]
12. The influence of the obesity paradox and chronic kidney disease on long-term survival in a Japanese cohort with peripheral arterial disease.
Kumakura H; Kanai H; Aizaki M; Mitsui K; Araki Y; Kasama S; Iwasaki T; Ichikawa S
J Vasc Surg; 2010 Jul; 52(1):110-7. PubMed ID: 20478682
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.
Triebswetter S; Gutjahr-Lengsfeld LJ; Schmidt KR; Drechsler C; Wanner C; Krane V
Am J Nephrol; 2018; 47(1):30-39. PubMed ID: 29320770
[TBL] [Abstract][Full Text] [Related]
14. Anthropometrics indices of obesity, and all-cause and cardiovascular disease-related mortality, in an Asian cohort with type 2 diabetes mellitus.
Lim RBT; Chen C; Naidoo N; Gay G; Tang WE; Seah D; Chen R; Tan NC; Lee J; Tai ES; Chia KS; Lim WY
Diabetes Metab; 2015 Sep; 41(4):291-300. PubMed ID: 25575429
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
Niskanen L; Turpeinen A; Penttilä I; Uusitupa MI
Diabetes Care; 1998 Nov; 21(11):1861-9. PubMed ID: 9802734
[TBL] [Abstract][Full Text] [Related]
16. Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
Mahaffey KW; Neal B; Perkovic V; de Zeeuw D; Fulcher G; Erondu N; Shaw W; Fabbrini E; Sun T; Li Q; Desai M; Matthews DR;
Circulation; 2018 Jan; 137(4):323-334. PubMed ID: 29133604
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes.
Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM
Diabetes Metab Res Rev; 2019 Feb; 35(2):e3093. PubMed ID: 30378236
[TBL] [Abstract][Full Text] [Related]
18. Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.
von Scholten BJ; Reinhard H; Hansen TW; Oellgaard J; Parving HH; Jacobsen PK; Rossing P
Diabetologia; 2016 Jul; 59(7):1549-1557. PubMed ID: 27033561
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study.
Cardoso CRL; Villela-Nogueira CA; Leite NC; Salles GF
Cardiovasc Diabetol; 2021 Sep; 20(1):193. PubMed ID: 34560854
[TBL] [Abstract][Full Text] [Related]
20. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
Murussi M; Campagnolo N; Beck MO; Gross JL; Silveiro SP
Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
